Researchers from the University of Birmingham and hospitals across the West Midlands have revealed how a common symptomless condition can develop into the blood cancer myeloma.
Jul 11, 2016
0
122
For the first time, researchers have discovered that some leukemia cells harvest energy resources from normal cells during chemotherapy, helping the cancer cells not only to survive, but actually thrive, after treatment.
Jun 2, 2016
0
7
Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise ...
May 25, 2016
0
478
Cancer researchers at the University of Cincinnati (UC) have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the ...
Apr 26, 2016
0
54
Stem cells in the bone marrow constantly give rise to new blood cells and are responsible for the maintenance of all vital blood components. However, errors during proliferation can change stem cell properties and cause tumours ...
Apr 18, 2016
0
17
An experimental antibody treatment decreased by half the number of cancer stem cells that drive the growth of tumors in nearly all patients with multiple myeloma, a cancer of the bone marrow and bone tissue, according to ...
Apr 15, 2016
0
790
There exist several oncogenes that drive cancer. In many cases, however, the oncogenes themselves are not sufficient and must be complemented with other mutations before cancer develops. Researchers at the Center for iPS ...
Mar 17, 2016
0
33
Cancer cells that lie 'snoozing' in the skeleton can be awakened - or left to slumber on - by changes in the bone that surrounds them, Australian scientists have shown. In a world first, researchers from the Garvan Institute ...
Dec 3, 2015
0
54
Bone Cancer Primary bone cancer called Osteosarcoma (OS) is a rare cancer most often affecting adolescents and children. While most bone cancers have their origin in other body tissues and spread to the bones through metastases, ...
Dec 2, 2015
0
1
(HealthDay)—Empliciti (elotuzumab), in combination with two other drugs, has been approved by the U.S. Food and Drug Administration to treat the blood cancer multiple myeloma. The drug is only approved for patients who ...
Nov 30, 2015
0
1
